BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results

  March 18, 2025

   · 

  24 min read
• Press Releases

  Moon Surgical receives FDA clearance for ScoPilot™ on Maestro, industry’s first AI-enhanced intraoperative capability, powered by NVIDIA Holoscan

  March 18, 2025

   · 

  2 min read
• Press Releases

  From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

  March 18, 2025

   · 

  6 min read
• Press Releases

  Alzheon to Present Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 at Dedicated Symposium at ADPD Conference in Vienna on April 1st, 2025

  March 18, 2025

   · 

  10 min read
• Press Releases

  Arbor Biotechnologies Announces $73.9 Million Series C Financing to Advance Novel Gene Editing Therapeutics

  March 18, 2025

   · 

  4 min read
• Press Releases

  Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

  March 18, 2025

   · 

  13 min read
• Press Releases

  Stoke Therapeutics Announces CEO Transition

  March 18, 2025

   · 

  9 min read
• Press Releases

  Ouster Launches Cloud Portal for Ouster Gemini Digital Lidar Perception Platform

  March 18, 2025

   · 

  5 min read
• Press Releases

  Labor Dr. Wisplinghoff and Genomic Testing Cooperative (GTC) Partner to Deploy GTC’s Comprehensive Suite of Tissue and Liquid Biopsy Testing for Solid Tumor and Hematologic Neoplasms in Germany

  March 18, 2025

   · 

  4 min read
• Press Releases

  Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease

  March 18, 2025

   · 

  8 min read